Citation

Faley B, Brooks A, Vartan CM, DiScala SL. J. Pain Palliat. Care Pharmacother. 2022; 36(4): 249-259.

Copyright

(Copyright © 2022, Informa - Taylor and Francis Group)

DOI

10.1080/15360288.2022.2113594

PMID

36044721

Abstract

Veterans Health Administration implemented the Opioid Safety Initiative (OSI) in 2013 to promote safe/rational opioid prescribing. West Palm Beach VA Healthcare System (WPBVAHCS) has been an outlier for the percentage of Veterans with chronic non-cancer pain receiving ≥90 mg Morphine Equivalent Daily Dosing (MEDD) in Veterans Integrated Service Networks (VISN) 8 since the 2016 fiscal year. The purpose was to determine the utility of a Pain Clinical Pharmacist Practitioner (CPP) identifying, reviewing, and approaching Veterans utilizing high-dose opioids for dose reevaluation and the impact on OSI metric post-opioid reevaluation. Pain CPP opioid education resulted in 28% (11/39) of Veterans undergoing an average 17.7 mg MEDD opioid dose reduction. For Veterans evaluated by Pain CPP, 83% (15/18) reported no change or improvement in average pain and PEG score. Pain CPP's implemented 48 interventions outside of opioid dose reduction, the most common related to naloxone. No documented opioid overdose events, hospitalizations for uncontrolled pain or mental health, suicide attempts or pain-related crisis interventions were reported. Pain CPP's are equipped to provide opioid education, address risk mitigation strategies, reassess pain regimens, and refer for non-pharmacologic modalities. Utilization of Pain CPP resources helps improve OSI metrics while providing safe comprehensive medication management (CMM) for chronic pain.

Language: en

Keywords

Humans; United States; opioid; United States Department of Veterans Affairs; Veterans; Pharmacists; pain; Analgesics, Opioid; *Veterans; *Chronic Pain/drug therapy; analgesics; clinical pharmacist practitioner; Morphine; Practice Patterns, Physicians'